Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload

NCT01039636 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Transfusional Iron Overload
Beta-thalassemia

Interventions

DRUG: FBS0701

Sponsor

FerroKin BioSciences, Inc.